Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.1 USD | 0.00% | +11.70% | -30.00% |
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company shows low valuation levels, with an enterprise value at 0.32 times its sales.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company has insufficient levels of profitability.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Electronic Equipment & Parts
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-30.00% | 3.8M | - | ||
-19.77% | 1.7B | - | ||
+141.12% | 133M | - | - | |
+14.39% | 122M | - | ||
+26.76% | 86.72M | - | - | |
-38.95% | 59.83M | - | C- | |
+8.77% | 51.64M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock
- Equities
- Stock BIO-key International, Inc. - Nasdaq
- Ratings BIO-key International, Inc.